1. Home
  2. ATAI vs BWB Comparison

ATAI vs BWB Comparison

Compare ATAI & BWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • BWB
  • Stock Information
  • Founded
  • ATAI 2018
  • BWB 2005
  • Country
  • ATAI Germany
  • BWB United States
  • Employees
  • ATAI N/A
  • BWB N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • BWB Major Banks
  • Sector
  • ATAI Health Care
  • BWB Finance
  • Exchange
  • ATAI Nasdaq
  • BWB Nasdaq
  • Market Cap
  • ATAI 444.7M
  • BWB 442.3M
  • IPO Year
  • ATAI 2021
  • BWB 2018
  • Fundamental
  • Price
  • ATAI $4.72
  • BWB $17.66
  • Analyst Decision
  • ATAI Strong Buy
  • BWB Strong Buy
  • Analyst Count
  • ATAI 3
  • BWB 2
  • Target Price
  • ATAI $13.33
  • BWB $20.00
  • AVG Volume (30 Days)
  • ATAI 4.8M
  • BWB 97.7K
  • Earning Date
  • ATAI 11-12-2025
  • BWB 10-22-2025
  • Dividend Yield
  • ATAI N/A
  • BWB N/A
  • EPS Growth
  • ATAI N/A
  • BWB 12.01
  • EPS
  • ATAI N/A
  • BWB 1.21
  • Revenue
  • ATAI $2,309,000.00
  • BWB $119,312,000.00
  • Revenue This Year
  • ATAI $712.99
  • BWB $35.51
  • Revenue Next Year
  • ATAI N/A
  • BWB $11.83
  • P/E Ratio
  • ATAI N/A
  • BWB $14.34
  • Revenue Growth
  • ATAI 510.85
  • BWB 12.23
  • 52 Week Low
  • ATAI $1.03
  • BWB $11.93
  • 52 Week High
  • ATAI $5.34
  • BWB $17.68
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 61.12
  • BWB 69.00
  • Support Level
  • ATAI $4.50
  • BWB $16.32
  • Resistance Level
  • ATAI $4.75
  • BWB $16.85
  • Average True Range (ATR)
  • ATAI 0.28
  • BWB 0.40
  • MACD
  • ATAI -0.04
  • BWB 0.08
  • Stochastic Oscillator
  • ATAI 59.28
  • BWB 96.69

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About BWB Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

Share on Social Networks: